Quantcast
Last updated on April 24, 2014 at 12:48 EDT

Latest Microarrays Stories

2013-04-25 08:33:49

SAN DIEGO, April 25, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the first quarter of 2013 after closing of the NASDAQ Global Market on Thursday, May 9, 2013. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm ET (2:00 pm...

2013-04-19 16:21:36

BROOKLYN, N.Y., April 19, 2013 /PRNewswire/ -- Today, Brooklyn based renewable energy firm Lumi*Solair was awarded the Environmental Protection Agency's prestigious Environmental Quality Award for 2013. Nominated by U.S. Senator Kirsten Gillibrand, a member of the Senate Environment and Public Works Committee, Lumi*Solair is being recognized for their commitment and significant contributions to greening New York City. Senator Gillibrand formally presented the award to Lumi*Solair...

2013-04-16 08:28:28

SAN DIEGO, April 16, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that earlier this month, its wholly owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), surpassed 100,000 MaterniT21(TM) PLUS test samples processed since the launch of its laboratory developed test (LDT) in October of 2011. The MaterniT21 PLUS test was the first commercial non-invasive prenatal test (NIPT)...

2013-04-08 08:30:24

REDWOOD CITY, Calif. and SANTA CLARA, Calif., April 8, 2013 /PRNewswire/ -- Ingenuity® Systems, a leading provider of biomedical information and analysis solutions, and Affymetrix®, Inc. (NASDAQ: AFFX) today announced that they will co-promote Ingenuity® iReport(TM) with Affymetrix expression microarray products effectively eliminating a bottleneck for researchers working with human, mouse and rat applications by coupling a fast and accurate statistical analysis and biological...

2013-03-21 08:29:58

SAN DIEGO, March 21, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that Sequenom Center for Molecular Medicine (SCMM) has launched an advanced new cystic fibrosis carrier screen test branded under the name Heredi-T(TM). The laboratory-developed test (LDT) is now available as a testing service to ordering physicians. The Heredi-T Cystic Fibrosis (CF) test analyzes 136 mutations and five variants...

2013-03-19 23:05:01

Research and Markets announces the addition of "Biochips and Microarrays - Technologies, Markets and Companies" to its catalogue. Dublin, Ireland (PRWEB) March 19, 2013 This report is an analysis of biochip/microarray markets based on technologies and applications. The report starts with a description of technologies as a basis for estimation of markets. Technologies include array comparative genomic hybridization (CGH), copy number variation (CNV), DNA methylation, ChIP-Chip, RNA splice...

2013-03-15 16:24:46

SAN DIEGO, March 15, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the 25(th) Annual Roth Conference at the Ritz-Carlton Hotel in Laguna Niguel, CA on March 17-20, 2013. William Welch, M.B.A, President and Chief Operating Officer, will present on Monday, March 18, 2013, beginning at 12:30 p.m. PT, to provide an overview of and update on the...

2013-03-14 08:28:54

LONDON, March 14, 2013 /PRNewswire/ -- The expiration of patents on several blockbuster drugs has been one of the major trends in the biotechnology sector in the last few years. As major pharmaceutical companies face increasing generic competition following patent expirations, they are likely to see a negative impact on their top-line. Big pharmaceutical companies have been looking to boost their product pipeline to offset the impact of the patent cliff. Another trend that could...

2013-03-07 16:24:55

Diagnostic Services Now Largest Contributor to Total Revenues SAN DIEGO, March 7, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $33.7 million and $89.7 million for the fourth quarter and full year of 2012, respectively. Net loss was $32.8 million, or $0.29 per share, and $117.1 million, or $1.03 per share, for the fourth quarter and full year, respectively. "It has been...

2013-03-05 08:28:15

SAN DIEGO, March 5, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the Barclays Global Healthcare Conference at the Loews Miami Hotel in Miami, FL on March 12-14, 2013. Ronald M. Lindsay, Ph.D., Director and EVP of Strategic Planning, will present on Wednesday, March 13, 2013, beginning at 4:45 p.m. ET, to provide an overview of and update on...